Virus-like particles (VLPs) are potential oral vaccine candidates, as their highly compact structure may allow them to withstand the harsh conditions of the gastro-intestinal (GI) environment. Hepatitis B core antigen (HBcAg) is an immunogenic protein that assembles into 30 or 34 nm diameter VLPs. Here, the stabilities of both the HBcAg polypeptide itself and the three-dimensional structure of the VLPs upon exposure to in vitro and ex vivo simulated gastric and intestinal fluids were investigated. Plant-expressed HBcAg VLPs were efficiently purified by sucrose density gradient and characterized. The purified VLPs did not show major chemical or physical instability upon exposure to the low pH conditions typically found in the stomach; however, they completely agglomerated upon acidification and subsequent pH neutralization.
4 been investigated as possible options for the successful oral delivery of proteins (Kammona and Kiparissides, 2012) .
Virus-like particles (VLPs) are viral mimics, whose structure resembles the antigenic conformation and repetitive nature of the whole virus from which they are derived, yet are noninfectious as they do not contain the viral genome (Jennings and Bachmann, 2008) . VLPs differ from conventional nanoparticles, as the virus-derived protein antigen self-assembles into particles and hence the carrier is the antigen itself. Moreover, VLPs could be particularly suitable oral vaccine candidates, as it has been suggested that their highly compact structure could enable them to withstand the harsh GI environment (Herbst-Kralovetz et al., 2010; Huang et al., 2005) .
For example, Norwalk VLPs, derived from Norwalk virus, a major pathogen responsible for human gastro-enteritis, have been shown to be stable at low pH and are trypsin resistant (Ausar et al., 2006) .
Hepatitis B virus (HBV) is a major human pathogen. Chronic infection with HBV is associated
with cirrhosis and primary liver cancer. The 42 nm HBV virion is formed by an external envelope surrounding an internal nucleocapsid, containing partially double-stranded DNA (Seitz et al., 2007) . This internal nucleocapsid results from the self-assembly of the nucleocapsid protein, a 21 kDa protein called Hepatitis B core antigen (HBcAg): 180 or 240 HBcAg monomers are arranged into 30 or 34 nm icosahedral particles (Birnbaum and Nassal, 1990; Crowther et al., 1994) . HBcAg VLPs can be produced as a recombinant protein in a variety of hosts, including plants (Huang et al., 2006; Mechtcheriakova et al., 2006; Sainsbury and Lomonossoff, 2008) . HBcAg has been shown to induce potent B and T cell responses (Milich et 5 al., 1997 (Milich et 5 al., , 1987 . The very strong immunogenicity of HBcAg is believed to be related to its particulate and polymeric nature. Over the years, HBcAg has also earned the reputation of being an exceptionally promising carrier for foreign epitope sequences: the conjugation of such epitopes to particulate carriers allows high density and repetitive display of these epitopes on the surface of particles (Grgacic and Anderson, 2006) . In addition, HBcAg is non-cytotoxic and is well tolerated in humans (Whitacre et al., 2009) .
In this study, HBcAg VLPs were produced in Nicotiana benthamiana using a transient expression system (Sainsbury and Lomonossoff, 2008) . The aim of this study was to investigate both the chemical and physical stability of HBcAg VLPs upon exposure to several digestive and denaturing conditions simulating the variable conditions of the GI environment. Such studies are a prelude to the development of plant-HBcAg VLPs as a source of oral vaccines.
Experimental Section

Materials
pEAQ-HT-HBcAgΔ176 (Peyret et al., 2015a; Sainsbury et al., 2009 ) is a construct designed to express the N-terminal 176 amino acids of HBcAg from the pEAQ transient expression vector.
Monoclonal mouse HBcAg antibody 10E11 was purchased from Abcam (UK). Anti-mouse HRP conjugated antibody was obtained from Invitrogen (UK) or Amersham Bioscience (UK).
Complete® Protease inhibitor tablets were purchased from Roche (UK), Miracloth from Merck (UK) and dialysis tubes from Spectrum Laboratories (Europe) or from Sigma -Aldrich (UK).
SDS-NuPAGE gels bis-tris Mini, NuPAGE MOPS buffer and NuPAGE LDS Sample Buffer were purchased from Invitrogen (UK). β-Mercaptoethanol, Brilliant Blue R Concentrate, 3,3',5,5'-tetramethylbenzidine dihydrochloride (TMB) substrate were purchased from Sigma (UK). InstantBlue stain was bought from Expedon (UK), SuperSignal West Dura Chemiluminescent Substrate from Thermo Scientific (UK) and polyvinylidene fluoride (PVDF) membranes and Hyperfilm from Amersham (UK). Pepsin (Ph Eur) from porcine gastric mucosa and pancreatin (≥ 3× USP) from porcine pancreas were purchased from Sigma-Aldrich (UK). A full-length intestine was obtained from a freshly killed pig at a local abattoir (H. G. Blake, Costessey Ltd, Norwich, UK). The animal was processed under standard UK legislation for food-producing animals, the intestine extracted within a few hours of slaughter, transported intact to the laboratory on ice and the intestinal fluids extracted within a short time.
HBcAg VLP expression, purification and characterization
Plant growth, protein expression, extraction and detection techniques
Nicotiana benthamiana plants were grown in a glasshouse at a fixed temperature of 25 ºC and used 3 to 4 weeks after pricking out. Suspensions of Agrobacterium tumefaciens (strain LBA 4404) containing pEAQ-HT-HBcAgΔ176 were pressure-infiltrated into N. benthamiana leaves, using needle-less syringes as described previously 20 . Infiltrated leaves were harvested 6 to 7 days post-infiltration. Extraction of the protein from the leaves was performed at 4 ºC by homogenisation in three volumes of extraction buffer 1 (50 mM Tris-HCl, pH 7.25 : 150 mM NaCl, 2 mM ethylenediaminetetraacetic acid (EDTA), 0.1% w/v Triton X-100, 1 mM dithiothreitol and Complete® tablet) or extraction buffer 2 (10 mM Tris-HCl, pH 8.4 : 120 mM NaCl, 1 mM EDTA, 0.75% w/v sodium deoxycholate, 1 mM dithiothreitol and a Complete®
Protease inhibitor tablet). The whole extract was then passed through a double layer of Miracloth and subsequently clarified by centrifugation at 12,000 x g in order to remove most plant cell 7 debris. All extractions were performed at 4 ºC. Plant expressed HBcAg VLPs were further purified by centrifugation of the protein extracts on 10-60% w/v sucrose density gradients prepared in 10 mM Tris-HCl pH 8.4, 120 mM NaCl. The gradients were centrifuged for 2.5
hours at 4°C at either 40,000 rpm in a SW41Ti rotor or at 30,000 rpm in a Surespin 630 rotor.
After centrifugation, the gradients were fractionated and the fractions dialysed against 10 mM Tris-HCl, 120 mM NaCl, pH 8.4 or phosphate buffer saline (PBS).
Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) -
Coomassie Blue Staining
Proteins were reduced and denatured by adding one volume of 3X LDS β-mercaptoethanol to two volumes of the samples. Samples were then heated to 100 ºC for 5 minutes. NuPAGE gels were run in 3-(N-morpholino)propanesulfonic acid (MOPS) buffer following the manufacturer's instructions. After electrophoresis, the protein bands were visualised by addition of Coomassie blue-protein stain for at least 1 hour.
Dot blot
Three μL of each sample were spotted onto PDVF membranes using 10 μL tips. Membranes were left to dry for 30 minutes and then blocked with the blocking buffer (5% w/v dried milk, 0.1% v/v Tween 20 in PBS) at 4 ºC overnight, before being incubated with monoclonal mouse HBcAg antibody, diluted 1:5000 in dot blot blocking buffer, for 2 hours. The membranes were then probed with anti-mouse horseradish peroxidase (HRP) conjugated secondary antibody, diluted 1:5000 in blocking buffer for a further 2 hours. Chemiluminescent HRP substrate was 8 used for the detection of the secondary antibody and captured on Hyperfilm (Sainsbury and Lomonossoff, 2008) .
Western blot
SDS-PAGE gels were run as described above and the proteins transferred to PVDF membranes immediately after the electrophoresis. The membranes were blocked with the blocking buffer (1% w/v bovine serum albumin, 1% w/v casein, 0.05% v/v Tween 20 in PBS) at 4 ºC overnight and before being incubated with anti-mouse horseradish peroxidase (HRP) conjugated secondary antibody, diluted 1:5000 in blocking buffer for 2 hours. Chemiluminescent HRP substrate was used for the detection of the secondary antibody and captured on Hyperfilm (Peyret et al., 2015a; Sainsbury and Lomonossoff, 2008) .
Transmission Electron Microscopy (TEM)
Samples diluted to an approximate concentration of 0.1 mg/mL were adsorbed onto hexagonal, plastic and carbon-coated copper grids, which were then washed three times with water. The grids were negatively stained with 2% w/v uranyl acetate before being imaged using a FEI Tecnal G2 20 Twin TEM with a built-in digital camera.
Native agarose gel electrophoresis
Agarose gels [1.2% w/v agarose in Tris/Borate/EDTA (3.03 g/L Tris-HCl, 5.5 g/L boric acid, 2 mM EDTA)] were usually run in duplicate at 60 V for 90 minutes (Aljabali et al., 2012 British Pharmacopeia, 2012) . The HBcAg solution in SGF was incubated at 37 °C for two hours. After incubation, it was layered on the top of a pH 1.2, 10 to 45% w/v sucrose density step gradient. Alternatively, purified HBcAg VLP preparations were incubated at pH 1.2 for two hours as described previously. At the end of the two hour incubation, the pH of the sample was neutralised by initial dropwise addition of 1 M NaOH. The neutralising agent was switched to 0.1 M NaOH once the pH became closer to neutrality. The sample was then layered on the top of 10 mM Tris-HCl, 120 mM NaCl pH 8.4, 10 to 45% w/v sucrose density step gradient. As a control, the purified HBcAg particles were diluted in a 10 mM TrisHCl pH 8.4, 120 mM NaCl solution. After two hours incubation, the control sample was layered on the top of a 10 mM Tris-HCl pH 8.4, 10 to 45% w/v sucrose density step gradient. Following ultracentrifugation, fractions were collected from the sucrose gradients and analysed by
Coomassie stained SDS-PAGE. If a precipitate formed at the bottom of the tube upon ultracentrifugation, it was re-suspended in 10 mM Tris-HCl, 120 mM NaCl pH 8.4 and analysed by Coomassie stained SDS-PAGE and Western blot.
For native agarose gel analysis, purified HBcAg VLPs in water were diluted 1:4 in each of the four acidic solutions: 10 mM HCl (pH 2) with 34 mM NaCl, 3.2 mM HCl (pH 2.5) with 34 mM NaCl, 1 mM HCl (pH 3) with 34 mM NaCl and 0.32 mM HCl (pH 3.5) with 34 mM NaCl. After two hours incubation, the four samples were loaded on agarose gel for electrophoresis. For TEM analysis, purified HBcAg VLPs in water were diluted 1:6 with a solution of 73 mM HCl to a final pH of 1.2. After two hours incubation at 37 °C, the pH was neutralised using aliquots of 400 mM NaHCO3. The resulting sample was used for imaging.
HBcAg Stability in Simulated Gastric Fluid (SGF) with Different Pepsin
Concentrations
Purified HBcAg VLPs were incubated at pH 1.2 with different concentrations of pepsin and a control with no pepsin (10, 3.2, 1, 0.5, 0.2, 0.1, 0.05, 0.01 and 0 mg/mL). After two hours incubation at 37 ºC, the samples were boiled to stop the enzymatic reaction and the proteins analysed by Western blotting.
HBcAg Stability in in vitro and ex vivo Intestinal Fluid
HBcAg Stability in Simulated Intestinal Fluid (SIF)
Simulated intestinal fluid (SIF) with pancreatin was prepared by mixing 7.7 mL of 0.2 M NaOH with 25 mL of a solution containing 6.8 g of K2PO4 and 50 mL of water. Porcine pancreatin (≥ 3× USP), 333 mg, was then added. The pH was then adjusted to 6.8 and the volume diluted to 100 mL with water (British Pharmacopeia, 2012) . SIF without pancreatin was For dot blot analysis, the sample resulting from the digestion and the positive control were loaded onto six different 10-60% w/v sucrose density gradients. After ultracentrifugation, fractions from the sucrose gradients were collected and subjected to dot blot analysis.
For native agarose gel electrophoresis, purified HBcAg was diluted 1:9 in SIF and incubated at 37º C for 30, 60, 120, 180 or 240 minutes. After the incubation the protease inhibitor solution was diluted 1:9 in each sample corresponding to different incubation times and they were immediately cooled on ice. A 1:9 dilution of HBcAg in SIF without pancreatin was used as positive control and a 1:9 dilution of water in SIF was used as a negative control. All samples were used for ethidium bromide stained and Coomassie stained agarose gel electrophoresis.
For TEM imaging, HBcAg was diluted 1:6 in SIF and the sample was incubated for 120 minutes. The enzymatic reaction was then stopped by 1:9 dilution of protease inhibitor solution in the digestion sample. The sample was kept cool on ice. TEM imaging was carried out within two hours of the end of the incubation.
Ex Vivo HBcAg Stability in Natural Intestinal Fluid (natIF)
Pig intestinal fluids were chosen as natural intestinal fluids (natIFs). The full-length intestine collected from the freshly killed animal was immediately transported to the laboratory and used for the collection of the luminal fluids. Four segments of approximately the same size from the proximal to the distal small intestine were divided and luminal fluid content was collected from each of the four segments separately. Small aliquots were made and frozen at -80 ºC until use.
Digestion experiments were conducted within ten weeks of collection of the fluids. For the SDS-PAGE analysis, aliquots from the four different segments of the small intestine were thawed and the solid content was pelleted by centrifugation at 9300 x g for 10 minutes. Aliquots from the most proximal part of the intestine (i.e. duodenum) were centrifuged twice to separate the more viscous phase. The supernatants constituted the natural intestinal fluid (natIF) of this study. The four natIFs from the proximal to the distal small intestine are referred to as natIF 1, natIF 2, natIF 3 and natIF 4 for the studies detailed below. Purified HBcAg aliquots were diluted 1:19 in each of the four natIFs and incubated at 37 ºC for 4 hours. At the end of the incubation, 1:3 dilutions of the four samples in water where made and then boiled to stop the enzymatic reaction. For a positive control, HBcAg aliquots were diluted 1:19 in PBS. Moreover, enzymatically inactive natIFs media were also used as positive controls: 1:3 dilutions of the natIFs in water and LDS β-mercaptoethanol were boiled for 10 minutes and then cooled and purified HBcAg was added in the same ratio as in the digestion samples. Negative controls were also created by diluting the PBS in natIFs. All samples were then analysed by Coomassie staining SDS-PAGE and Western blot.
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For dot blots, purified HBcAg aliquots were diluted 1:19 in the four natIFs and incubated at 37 ºC for four hours. Then the proteolysis was stopped by the addition of 1:9 dilution of protease inhibitor solutions. For a positive control, HBcAg was diluted 1:19 in PBS. The control and the digestion samples were loaded onto five identical sucrose density gradients. After ultracentrifugation, fractions from the sucrose gradients were collected and analysed by dot blot using anti-HBcAg mouse monoclonal antibody.
Results and Discussion
Purification and analysis of plant-expressed HBcAg
Sainsbury and Lomonossoff 14 showed that HBcAg could be expressed using the CPMV-HT system up to yields of approximately 1 g per kg of fresh weight tissue. Subsequently methods for the efficient purification of plant-expressed HBcAg VLPs have been developed (Peyret, 2015; Peyret et al., 2015a Peyret et al., , 2015b . Here, the final purification of VLPs from the crude extract was HBcAg. As expected, HBcAg was also detected in the original crude extract (lane E). In the HBcAg-rich lanes, it is also possible to notice a persistent 40 kDa band. The band was also observed by others and corresponds to HBcAg dimers, which are resistant to denaturation (Huang et al., 2006; Mechtcheriakova et al., 2006) . Even larger size HBcAg multimeric structures have been detected in denaturing gel electrophoresis (Broos et al., 2007) . Weaker bands of circa 15 kDa monomeric HBcAg and its dimer of 30 kDa can also be seen and they are possibly the result of partial enzymatic digestion of HBcAg by plant proteins.
These results are in accordance with previous studies on HBcAg (Birnbaum and Nassal, 1990; Broos et al., 2007; Huang et al., 2006) . (Lee and Tan, 2008; Wingfield et al., 1995) . Overall, the Coomassie-stained SDS-PAGE gel, the native agarose gel and the TEM showed a very high degree of purification of the VLPs upon ultracentrifugation. Approximately, a purity of > 90% could be estimated by visualization of the Coomassie-stained gel (Figure 1 B left side, lanes 4 and 5). 
HBcAg in vitro and ex-vivo stability in gastro-intestinal media
A previous study on plant-expressed HBcAg VLPs showed that oral administration of plant extracts containing HBcAg elicited only poor immunogenicity in mice and it was speculated that this could have been due to the gastric degradation or the physical disassembly of the antigen (Huang et al., 2006) . Hence, the stability of plant-expressed HBcAg VLPs in gastric and intestinal conditions was investigated here: each experiment consisted of incubation of purified VLPs in the bio-relevant media, followed by a post-incubation assessment of their physical and chemical stability.
HBcAg Stability in Simulated Gastric Fluid (SGF)
Initially the stability of plant-expressed HBcAg VLPs was investigated at the acidic pH of the SGF (pH 1.2). Three experiments were carried out (Figure 2 . A, B and C): in one case purified HBcAg VLPs were incubated for 2 hours at pH 8.4 and then separated by sucrose gradient ultracentrifugation, with fractions of the gradient prepared at the same pH (control, Figure 2 . A).
In the second case HBcAg VLPs were incubated for 2 hours at pH 1.2 and then sample separated by sucrose gradient ultracentrifugation, set up in a way to maintain the pH of the sucrose fractions consistent with the incubation pH (Figure 2 . B). In the third case, HBcAg VLPs were incubated for 2 hours at pH 1.2, then, following neutralization, the sample was separated by sucrose gradient ultracentrifugation, with sucrose fractions prepared at pH 8.4 (Figure 2 . C). However, a precipitate was visible at the bottom of the tube used for the ultracentrifugation of the sample. This precipitate was re-suspended and analysed by SDS-PAGE, revealing the presence of a band of a similar size to HBcAg, which reacted with anti-HBcAg antibodies in a Western blot (Fig. 2C) . The fact that HBcAg was not found in any of the fractions of the gradient but in a precipitate at the bottom of the tube indicates that HBcAg was not present as intact VLP, nor as a disassembled monomeric or multimeric form but as a high molecular weight aggregate.
For a final characterisation of HBcAg in SGF without pepsin, purified HBcAg particles were incubated in SGF at pH 1.2 for two hours and then the acidity was neutralised. This sample was used for TEM imaging. The TEM image (Figure 2 . D) showed that the typical HBcAg VLPs detected in the control sample could not be found in the acidified and neutralised sample; instead aggregates could be seen, probably representing aggregated VLPs.
These results taken together indicate that the HBcAg polypeptide is chemically stable at pH 1.2. However, the VLPs tend to partially disassemble at this pH (Figure 2 . B). When the pH is raised the dissociated subunits tend to form aggregates rather than reassemble into VLPs. (Figure   2 . C and D). These results demonstrate that HBcAg VLPs are likely to be physically unstable in the stomach environment of humans. Although it is possible that the low pH would not cause a complete disassembly of the capsid, the subsequent passage to a more neutral pH in the intestine would induce aggregation. However, the actual pH of human gastric fluid in fasted state is not strictly 1.2, but is in the range between 1.0 and 2.5 (Evans et al., 1988) . Hence, to better delineate HBcAg VLP physical stability in gastric conditions, the threshold pH for HBcAg VLP stability was investigated using native agarose gel electrophoresis.
The ethidium bromide-stained agarose gel ( 
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This result is in accordance with Newman et al 25 : in that case, it was shown that bacterially expressed HBcAg incubated at pH 2.0 for only 30 minutes was unstable and it remained blocked in the well (Newman et al., 2003) . Overall, in the current study, the native agarose gel electrophoresis revealed that this complete loss of the physical stability upon incubation of HBcAg for two hours in acid and further neutralisation occurs at pH values below 3 to 3.5
( Figure 3 ). The fact that the VLP particulate structure was lost upon incubation in media at pH values lower than pH 3 to 3.5 suggests that HBcAg would be unstable in the fasted gastric environment, i.e. pH 1 to pH 2.5 (Evans et al., 1988) . However, it was reported that the average stomach pH can remain > 3.5 for the first three hours after a meal (Kalantzi et al., 2006) .
Therefore, it could be expected that the VLP structure could be physically stable at the pH of the fed stomach.
The stability of purified plant-expressed HBcAg was also evaluated after 2 hours incubation in SGF in the presence of the enzyme pepsin. The British Pharmacopoeia (2012) formula of SGF has a fixed 3.2 g/L pepsin (Ph Eur) concentration; however variations of pepsin activity up to four orders of magnitude have been reported in humans (Gomes et al., 2003) . 
HBcAg in Intestinal Fluids: An In Vitro and Ex Vivo Stability Approach
The second barrier that HBcAg will encounter upon oral administration is the harsh environment of the small intestine: it contains several enzymes, including trypsin and chymotrypsin, which could digest a protein antigen To determine whether the major digestion product (17 kDa) was in the form of VLPs, the digested samples were examined on sucrose gradients. The pancreatin present in the SIF contains several pancreatic proteases, including trypsin, chymotrypsin and elastase, which could potentially digest antigens. Interestingly, it was reported in a virology study, that HBcAg, expressed in Xenopus oocytes, was partially digested into smaller proteins upon incubation in trypsin: the main residue was a circa 17 kDa protein, but several intermediate forms ranging between 17 and 21 kDa were also detected, corresponding to different cleavage sites for trypsin at the C-terminus. The trypsin digestion did not seem to affect the particle assembly (Seifer and Standring, 1994) . It is worth remembering that HBcAg bears in its monomeric structure a C-terminal tail arginine-rich domain. This domain is not essential for the assembly and stabilisation of the monomers into a VLP (Birnbaum and Nassal, 1990; Zheng et al., 1992) . Intriguingly, it was demonstrated that the trypsin digests only these C-terminus sequences, which were "non-essential" for the particle assembly. The authors suggested that these C-terminal regions are accessible to the enzymatic attack, while other possible cleavage sites are relatively sequestered inside the VLP structure. Moreover, it was shown that the maximal trypsin cleavage was achieved after only 8 minutes of incubation (Seifer and Standring, 1994) . The results obtained in SIF with pancreatin strongly suggest that the main pancreatic enzyme involved in the digestion of HBcAg is trypsin. In fact the intestinal bio-relevant media used determined a similar pattern of digestion to that indicated in the study, described by Saifer and Standring (Seifer and Standring, 1994) .
These results suggest that HBcAg VLPs, though partially digested, could still withstand the intestinal environment while maintaining the particulate morphology and immunogenicity. In fact, it was found that all the major epitopes mediating T-and B-cell responses are not found in the C-terminal arginine rich region (Vanlandschoot et al., 2003) , which is digested by the trypsin.
Despite the fact that pancreatic enzymes are the main proteases in the intestine, it has been recently reported that pancreatic proteases only partially contribute to the total intestinal enzymatic activity in animal models (Reuter et al., 2009) . Therefore, the stability of HBcAg in natural intestinal fluid (natIF) of the pig was investigated, in order to complement the in vitro model. The whole pig small intestine was divided into four parts of approximately same length and natIFs were collected from the resulting four sections and named natIF 1, natIF 2, natIF 3 and natIF 4 from the proximal to the distal regions. For evaluating the extent of digestion, HBcAg VLPs were incubated in each of these natural media at 37 ºC for 4 hours and the fate of HBcAg was subsequently evaluated. . In natIF 4 a weak 20 kDa band was also present, probably corresponding to intact HBcAg. As expected, no bands were seen in the negative controls (lanes 11 to 14).
In a similar experiment samples were not boiled, so that the VLPs could maintain their native physical structure. However, the enzymatic reaction was stopped at the end of the digestion study by adding a protease inhibitor solution. Sucrose density gradient ultracentrifugation was then carried out in parallel for the four samples, corresponding to the digestion of HBcAg in the four natIFs, and for the control sample of HBcAg in PBS. After ultracentrifugation, fractions were collected and analysed by dot blot. These results suggest that, despite the fact that the natural intestinal fluids have a much wider pool of proteases than just the pancreatic proteases used in vitro (Reuter et al., 2009) , the main product of HBcAg digestion appears to be the same, i.e. a 16-17 kDa immunogenic protein still assembled as a VLP. In terms of physical stability of HBcAg in pig small intestinal fluids, the detection of some minor anti-HBcAg signal in the less dense fractions of the gradient suggested that partial disassembly took place upon incubation of HBcAg natIFs. However most of the immunoreactivity was still detected in the 30 and 40% w/v sucrose gradient fractions, where usually intact VLPs are found. It can be concluded that HBcAg appeared chemically unstable upon incubation in pig intestinal fluids. However, these data also suggest that the principal digestion products were still immunoreactive and that HBcAg was still mainly present as a VLP.
The use of the pig natIFs here was part of a preliminary study to explore their use in the evaluation of the intestinal fate of administered pharmaceutical products. Here, the results of the pig natIF experiments were in line with those of the more conventional SIF experiments, suggesting that this approach has merit and agreeing with the previous work in this area by Wang et al (2015) .
Conclusions
This study aimed to gain a better understanding of the stability of purified HBcAg in the gastro-intestinal (GI) tract: it was demonstrated that HBcAg VLPs were highly physically and chemically unstable in simulated human gastric media. Moreover, it was shown that HBcAg was digested in simulated human intestinal fluid (SIF) and ex-vivo pig intestinal fluids, but surprisingly the main digested form of HBcAg maintained the particulate three-dimensional structure and the most antigenic epitopes. This offers an important prediction about the stability of HBcAg administered orally and can help interpret previous findings: previous research showed that HBcAg could elicit only weak immunogenicity upon oral administration in mice, hence it was speculated that exposure to the gastric environment could have resulted in either major chemical degradation or particulate disassembly before the VLP could enter into contact with the mucosal surfaces of the intestine (Huang et al., 2006) . This assumption is supported by the current work, which indicates that HBcAg gastric instability, both in terms of chemical digestion and physical disassembly, can constitute a major obstacle to HBcAg oral delivery. The measured stability of HBcAg in SGF, SIF and natIFs in this study is likely to closely reflect its human in vivo stability, as it has recently been demonstrated that trends of digestion of peptide drugs in these media correlated well with their digestion in human fluids. The current findings are an important step towards understanding the complex oral immunogenicity of HBcAg.
However, the current results also suggest that if the gastric instability could be bypassed, HBcAg could circulate through the human small intestine withstanding major degradation. Our current work is investigating this with a view to developing a patient-friendly orally-administered formulation which will protect the HBcAg from the harsh conditions in the stomach but release it intact in the intestine where it can exert its immunogenic effect.
Finally, in this paper a novel methodology to investigate the oral stability of VLPs has been put forward: the fate of the VLP was evaluated not only in terms of chemical digestion of the primary structure, but also in terms of the stability of the three-dimensional quaternary structure.
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